Opium use, particularly in low doses, is a common practice among adults in northeastern Iran. We aimed to investigate the association between opium use and subsequent mortality from disorders of the digestive tract.
INTRODUCTION
Opium is the air-dried extract of the opium poppy, Papaver somniferum . Th is extract includes a large number of molecules, including narcotic alkaloids (e.g., morphine and codeine), non-narcotic alkaloids (e.g., papaverine, thebaine, and noscapine), and non-alkaloids (e.g., sugars and meconic acid) ( 1 ) . Th ese compounds may aff ect human physiology and health in many diff erent ways, the totality of which could only be assessed in long-term human studies.
Opium has long been used for medical and recreational purposes in many parts of the world, including Iran. Avicenna ' s tenth century article was the main reference for medicinal use of opium until the nineteenth century ( 2 ) . A combination of
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criminalization of opium use, as well as availability of other psychoactive drugs such as cannabis, has resulted in lower use of opium in the developed world. Yet opium is still commonly used in other parts of the world, mainly in Western and Central Asia ( 1 ) . Globally, an estimated 13 -22 million people, mostly from Asian countries, consumed opium and its derivatives in 2008 ( 3 ) .
A popular belief among lay people, and even perhaps among the older generation of physicians in Western and Central Asia, is that long-term use of low-dose opium can prolong survival by preventing chronic diseases, such as diabetes mellitus, cardiovascular diseases, and cancer. However, published data do not support this hypothesis. Several case -control studies and case series have suggested deleterious eff ects of opium consumption, associating its use with higher risk of cardiovascular outcomes and a variety of cancers ( 4 -14 ) . A recent report from the Golestan Cohort Study (GCS) showed that opium use, even in low doses, was associated with a near doubling of all-cause mortality ( 15 ) .
Opiates are metabolized principally in the liver, and chronic ingestion of morphine in mice has been shown to cause histopathological changes in the liver resulting in abnormal liver function tests ( 16 ) . In humans, long-term use of opiates, particularly morphine, can commonly cause constipation, which results from opium ' s disruption of neurotransmission in the enteric nervous system, leading to decreased motility and decreased secretion of water, electrolytes, and bile in the gastrointestinal (GI) tract ( 17 ) . Th us, opium use may be involved in the etiology of multiple digestive tract disorders. Several studies have reported an association between opium use and esophageal cancer ( 4, 18, 19 ) or gastric cancer ( 20, 21 ) , but no study has reported on the association between opium use and all digestive disease-related mortality, including deaths from diseases with nonmalignant etiologies. We conducted this study to investigate the association between opium use and mortality due to GI and liver diseases.
METHODS

Study population
Th e GCS is a prospective cohort study of 50,045 adults, aged 40 -75 years, from Golestan province of Iran who were recruited between January 2004 and June 2008. A detailed description of this study is available elsewhere ( 22, 23 ) . In summary, a total of 10,033 participants were enrolled from Gonbad City, the largest city in the study area, with participation rates of approximately 70 % and 50 % for women and men, respectively. In addition, 40,012 participants were enrolled from 326 villages, with participation rates of 84 % for women and 70 % for men. Figure 1 shows the fl ow chart of study recruitment. Seventy-fi ve percent of the study participants were Turkmen ethnics, who likely descended from Turkic tribes and migrated from the Altai Mountains on the border of China and Mongolia to northern Iran. Turkmens presently live in Turkmenistan (part of the Ancient Iranian Empire) and northeastern Iran, primarily in Golestan province.
Opium use was assessed using a structured questionnaire, which included detailed questions about the age of starting opium use, daily amount, and frequency of use (how many days a week if weekly or more), routes of intake, opium types (teriak, sukhteh, shireh, and heroin) ( 15 ) , and the age of quitting consumption, if the person had quit. If subjects used several types of opium, or they used opium intermittently (stopped and resumed use), data were recorded separately for each type and period of use. Th e accuracy of self-reported opium use in this population has been evaluated by comparing the presence of codeine or morphine in urine 
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Opium Use and Digestive Mortality samples of 150 cohort participants with self-reported opium use. Th at study showed a relatively high accuracy for self-report of opium use in these cohort participants, with a sensitivity of 0.93 and a specifi city of 0.89 ( 24 ) . Th e GCS methods were approved by the ethical review boards of Digestive Disease Research Center, the International Agency for Research on Cancer, and the National Cancer Institute, and all participants signed a written informed consent at enrollment.
Cause of death ascertainment
Th e follow-up methods and cause of death ascertainment in the GCS have been described in detail elsewhere ( 15, 25 ) . In brief, the follow-up team uses several methods, including annual phone calls to study participants, communicating with local health workers, and collecting data from local death registries and cancer registries, to either reach the study participants or to collect information on the occurrence and cause of death. All cohort participants are phoned annually and asked about vital status and any admission to a hospital or outpatient clinic, and the information is recorded. If the participant is not reached aft er seven phone calls made in a 2-week period, friends or local health workers are contacted. Using these methods, the follow-up success rate so far is over 99 % .
If a death is reported, the physician in the follow-up team uses a validated verbal autopsy questionnaire to interview the closest relative of the deceased ( 25 ) . In addition to administration of the verbal autopsy for each deceased participant, the follow-up team actively pursues and collects all available medical documents such as hospital charts, physician notes, electrocardiography reports, endoscopy results, and pathology reports from all medical centers of Golestan province and the neighboring provinces. Verbal autopsies have been carried out for 100 % of deaths, and additional medical documents have been collected for 65 % . To ascertain the cause of death, two internists independently review all collected medical documents as well as the completed verbal autopsy questionnaire and make their own diagnosis, according to the ICD-10 coding system (international classifi cation of diseases, 10th revision). If the two diagnoses are concordant, the diagnosis is made. In case of discordance, a third more experienced internist reviews all documents and the two initial diagnoses to make the fi nal diagnosis. If a fi nal diagnosis cannot be made for any reason, the cause of death is coded as " unknown " . For the purpose of this paper, consistent with a national survey in 2009 ( 26 ), we focused on main causes of GI causes of death, both malignant and non-malignant. Th e major malignant causes of death were esophageal and gastric cancers, and to a lesser extent colorectal and pancreatic cancers. Th e major non-malignant cause of death was liver cirrhosis, and less frequently, other alcoholic liver disease, cholelithiasis, and other infl ammatory liver diseases.
Statistical analysis
Statistical analyses were conducted with STATA statistical software, version 11 (STATA Corp, College Station, TX). Standardized mortality rates were calculated using the World Population 2000 as the reference population. Age-adjusted relative risks (RRs) were obtained by dividing standardized mortality rates.
We fi tted Cox proportional hazards regression models, with age as the timescale, to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs) for mortality due to digestive diseases in association with opium use. Th e proportional hazard assumption was verifi ed using Schoenfeld residuals. Follow-up continued until loss to follow-up, death, or 17 December 2012, whichever came fi rst. We also adjusted the Cox models for sex, ethnicity (Turkmen or other), place of residence (urban or rural), cigarette smoking (ever or never), alcohol consumption (ever or never), and hepatitis B virus (HBV) infection. Inclusion of other variables, including level of education, marital status, body mass index, history of diabetes, and consumption of fruits and vegetables did not have a material eff ect on the association between opium use and GI mortality. Th erefore, we did not include them in the fully adjusted Cox models to avoid instability of the models due to non-event strata in some categories of those variables.
We defi ned participants as an ever opium user if they used opium at least once a week for at least 6 months. We additionally defi ned former opium users as participants who had reported quitting their habit at least 1 year before the enrollment. For current users, duration of use and cumulative use (defi ned as duration of use, in days, multiplied by daily amount of opium use, in nokhods, a local unit for opium consumption that weighs about 200 mg) were categorized into fi ft hs to test for dose -response relationships. Th e opiate types that were included in the analyses were teriak (raw opium), sukhteh, shireh, and heroin. Sukhteh is the dry, black residue of smoked teriak, which sticks to the opium pipe. It can be scraped from the opium pipe and ingested. Shireh is a refi ned opium product oft en made by boiling a combination of opium and sukhteh in hot water and passing the solution through fi lters several times. We estimated HRs stratifi ed by routes of administration, which included opium smoking, ingestion, or both. We did not consider injection as a method of opium use because heroin, the only intravenous opiate used in the study area, was used by only a very small number of participants.
Sensitivity analysis to assess reverse causality, by excluding deaths occurring in the fi rst 12 months of follow-up, was also conducted. Th e possibility of reverse causality was also addressed by excluding from analysis participants who reported starting opium use aft er being diagnosed with a major chronic disease, including coronary heart disease, cerebrovascular accidents, diabetes mellitus, and hypertension.
RESULTS
At baseline, 17 % ( n = 8,487) of the cohort participants reported ever opium use, with a mean duration of 12.7 years. During the follow-up period, 474 deaths from digestive diseases were reported, including 387 due to malignant and 87 due to non-malignant causes. Th e median follow-up time was 6.3 years, during which a total number of 332 (0.7 % ) participants were lost to follow-up and 3,110 (6.2 % ) died.
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Malekzadeh et al. Table 1 shows the distribution and age-adjusted RRs of digestive disease-related mortality in several subgroups of cohort participants. Results are shown separately for malignant and non-malignant causes. For deaths related to GI malignancies, male gender (RR = 2.0), being of Turkmen ethnicity (RR = 1.8), cigarette smoking (RR = 3.0), and opium use (RR = 1.8) were risk factors. For nonmalignant digestive-disease related causes of death, male gender (RR = 1.8), having university education (RR = 6.0), alcohol consumption (RR = 3.3), cigarette smoking (RR = 2.4), and opium use (RR = 3.0) were associated with increased risk.
Aft er adjusting for potential confounders, ever opium use was associated with a 55 % increased risk of all GI mortalities (HR = 1.55, 95 % CI = 1.24 -1.93; Table 2 ). Th e risk was greater for non-malignant (HR = 2.60, 95 % CI = 1.57 -4.31) than malignant causes (1.38, 95 % CI = 1.07 -1.76; P heterogeneity = 0.035). Th e risks for all digestive mortality and for malignant causes appeared to be dose dependent ( P trend = 0.037 and 0.030, respectively), but no trend was observed for non-malignant causes of mortality ( P trend = 0.73).
Th e mortality HRs by type of opium usage are also shown in Table 2 . Th ere was no evidence for heterogeneity of risk between 
Opium Use and Digestive Mortality changes in the results were observed. Excluding participants who reported starting opium use aft er being diagnosed with a major chronic disease did not materially change the results. When we further adjusted the model for self-reported history of liver disease, we also found no major change in results. Of the 40 participants who reported a history of liver disease at enrollment, 1 died of liver cirrhosis, 3 died from other non-digestive diseaserelated causes, and 36 were still alive on the day of last follow-up report. Cigarette smoking, alcohol consumption, and HBV infection are among the well-known risk factors for various types of GI diseases. Th erefore, we compared the strength of associations of opium teriak and shireh opium use for any of the mortality end points. Similarly, the route of administration was not an important determinant of digestive disease mortality risk. Table 3 shows the results for the major individual causes of GI mortality. Th e three most common causes of GI mortality were esophageal cancer, gastric cancer, and liver cirrhosis. Of these, the risk of esophageal cancer and cirrhosis was statistically significantly increased by opium use, whereas the risk of gastric cancer was not. Table 3 also shows the results of the sensitivity analysis that excluded deaths occurring in the fi rst 12 months aft er enrollment. Although the HRs were slightly shift ed toward null, no major ( 27 ) . In these areas, alcohol consumers are relatively few, consume relatively little alcohol, and may come from diff erent socioeconomic backgrounds.
DISCUSSION
Th e results of this study, which are based on an average 6.3 years of follow-up of 50,045 individuals, showed that opium use was associated with statistically signifi cant increased risks of all-cause GI mortality, malignant causes of GI mortality, and non-malignant causes of GI mortality. For all-cause GI mortality ( n = 474), the estimated increased risk was 55 % aft er adjusting for a number of potential confounders, including age, sex, residential place, ethnicity, cigarette smoking, alcohol consumption, and HBV infection. Interestingly, the HR point estimate for the association between opium use and GI mortality (1.55) was slightly higher than that for cigarette smoking and GI mortality (1.43). A clear dose -response association was also found between opium use and all GI mortality. And aft er we eliminated cases diagnosed within the fi rst year of follow-up, opium use was still signifi cantly associated with increased risk of GI mortality. Th e two main types of opium used in the area, teriak and shireh, were both associated with increased risk of GI mortality. Similarly, both major routes of use, smoking and ingestion, were associated with increased risk.
When the results were stratifi ed by malignant and non-malignant causes, higher risks of both categories were associated with opium use and the majority of the overall associations were upheld. However, although non-malignant causes were more strongly associated with opium use than malignant causes (HR of 2.60 vs. 1.38), it was only the malignant causes that showed an obvious dose -response relationship. When stratifi ed further, among the more common causes of GI mortality, risks of esophageal cancer and cirrhosis, but not gastric cancer, were statistically signifi cantly associated with opium use. Our study showed a signifi cant association between opium use and esophageal cancer mortality. It is important to know whether or not this association is causal. Possible explanations other than causality include reverse causality, confounding, selection bias, reporting bias, ascertainment bias, and random error ( 28 ) . To reduce the possibility of reverse causality, we excluded from analysis all those who died within 1 year of enrollment in the study, yet the results did not change substantially. In another sensitivity analysis, we excluded those who reported opium use aft er receiving the diagnosis of a major chronic disease, and again the results did not change. We also adjusted for all major potential confounders, including age, sex, and cigarette smoking. Th e possibility of selection bias is also unlikely, as all cases and controls were from the same cohort. And as the results were obtained from a cohort study, the possibility of reporting bias is also low. Ascertainment bias is unlikely, as diagnosis of esophageal and gastric cancers is relatively straightforward, and the physicians who reviewed the mortality cases had no preconceived idea that opium could increase the risk of mortality due to benign digestive diseases. Although there are relatively few studies on opium and GI diseases, our results are consistent with the previous literature, and therefore the possibility of random error is low. Epidemiologic studies in the 1970s began to study the eff ects of opium use on health ( 5,18,29 -31 ). Among these, Major chronic diseases included coronary heart disease, cerebrovascular accidents, diabetes melitus, and hypertension.
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Opium Use and Digestive Mortality and morphine-like agents can increase liver enzymes and lead to perivenular and focal hepatocellular necrosis ( 16,39 -41 ) . In one study, chronic usage of morphine in albino rats increased infl ammatory infi ltration and focal parenchymal necrosis in the liver, in addition to an increase in the total lipid content of hepatocytes, leading to hepatic damage ( 42 ) . Furthermore, a growing body of knowledge suggests a pivotal role for GI microbiota in the etiology of some chronic diseases ( 43, 44 ) . As opium has been shown to decrease the secretion of water, electrolytes, and bile acids into the GI tract, and to signifi cantly reduce GI motility ( 17 ) , it could cause considerable changes in GI microbiota, which could make opium users prone to both infl ammatory and malignant diseases of the GI tract, as well as other chronic diseases ( 43 -46 ) . Th e adverse eff ects of opium on health are not limited to GI cancers or liver diseases ( 1, 47, 48 ) . Other cross-sectional or case -control studies and a large cohort study ( 15 ) have shown that opium use can increase the risk of lung cancer ( 49 ) , bladder cancer ( 6 -8,50 ) , cardiovascular diseases ( 9 -14 ) , and respiratory diseases ( 51 -53 ) .
Raw opium is a complex mixture containing three primary alkaloids of pharmacologic interest, morphine, codeine, and thebaine. Th e percentage of these alkaloids in raw opium varies dramatically due to diff erences in processing, and their concentration tends to rise progressively as the latex dries. Th us, the inherent variability of raw opium makes it diffi cult to make a direct dosage comparison between use of opium and use of pharmaceutical opiates or synthetic opiates. In addition, this study primarily evaluated the recreational use of opium, by smoking or ingestion, and did not look directly at potential deleterious eff ects of therapeutic or palliative use of opioid derivatives in the management of chronic disease, including cancer and non-cancer pain. Th e results of this study are still relevant, however, to clinical practice in countries where recreational opium use is not widespread. Th ere is now ample evidence in the literature that many patients in the United States, Canada, Australia and Europe who use long-term prescribed opioids, such as morphine, hydromorphone, codeine, and oxycodone, for chronic non-cancer pain are also at increased risk of dying from digestive disease, cardiovascular disease, and cancer, similar to the opium users in Golestan ( 54 -62 ) . A cohort study in United States has shown that in adults with arthritis, all-cause mortality is almost twice as high in patients prescribed opioids as in those prescribed non-steroidal anti-infl ammatory drugs ( 54 ) . A study from Canada also found that adults who are on long-term prescribed opioids are more likely to die than a control population, and that deaths from overdose are not the main cause of this diff erence ( 56, 57 ) . And a study of 1,193 cases from Australia comparing methadone to heroin found that exposure to methadone was more deleterious than exposure to heroin (a more refi ned product) for several chronic diseases ( 62, 63 ) . Th e results of the current study are signifi cant for physicians practicing throughout the world, including Western countries, because they add to the evidence that, although not completely understood, opioids have substantial risks for human health, and these risks are probably related to the considerable growth a household case -control study by Ghadirian et al. suggested an increased risk of esophageal cancer associated with opium use ( 5 ). Further case -control studies that have been conducted over the past decade have shown increased risk of esophageal cancer ( 4, 32 ) and gastric cancer ( 20 ) in relation to opium use. Our results add to the literature that esophageal cancer could be caused by opium use.
Our results showed a strong association between opium use and death from liver cirrhosis, even aft er adjustment for HBV infection. We also found a nearly threefold increased risk of mortality from other non-malignant GI diseases in current opium users. Again, the question of causality is an important one. For reasons similar to those mentioned above, the possibility of selection or reporting bias is small. Only one person who died of cirrhosis had reported a history of liver disease before enrollment, which makes reverse causality unlikely. Other important causes of cirrhosis in Golestan province and throughout Iran are viral hepatitis ( 33 ) and nonalcoholic steatohepatitis, a condition that has shown an increasing incidence trend in recent years ( 26 ) and is associated with type II diabetes, obesity, and hyperlipidemia ( 34 ) . Although alcohol consumption has been shown to be another major risk factor for liver cirrhosis, it has already been shown that alcohol drinking is very rare in this area ( 4, 23 ) . Aft er adjusting our models for sex, ethnicity, place of residence, cigarette smoking, alcohol consumption, and HBV infection, in addition to other potential confounders, the association between opium use and mortality due to cirrhosis remained signifi cant. Finally, although the results of our study were statistically signifi cant, future studies with similar results would be helpful to eliminate the possibility of random error.
Our results did not show a statistically signifi cant association between opium use and gastric cancer deaths, which is unlike what has been shown in a case -control study from this area ( 20 ) and a small cohort conducted in Northwest of Iran ( 21 ) . Th is may be due to a lack of eff ect, or due to inadequate power to detect the association, as there were only 125 deaths from gastric cancer in this study. We also observed no association between opium use and deaths from other cancers.
Opiates have analgesic, expectorant, and antitussive properties, but may also slow peristalsis in the GI tract. Morphine is the most prevalent and important alkaloid in opium, comprising 15 % of opium, and it is responsible for most of its harmful eff ects. Other alkaloids, like codeine (0.7 -5 % ), and thebaine (0.1 -2.5 % ) also have some deleterious eff ects ( 2 ) . In addition to the compounds present in raw opium, opium smoke and opium dross contain additional compounds formed during pyrolysis, including polycyclic aromatic hydrocarbons, heterocyclic aromatic hydrocarbons, primary aromatic amines, and N-nitrosamines, which are highly active mutagens and are thought to be the reason for the oncogenicity of opium ( 4,15,18 -20,31,35,36 ) .
Several mechanisms could be proposed for the adverse eff ect of opium on the liver. Morphine, like other opiate alkaloids, is metabolized principally in the liver, via conjugation with glucuronic acid ( 37 ) . Similar to other substances metabolized by the liver, morphine exposure may result in some levels of hepatotoxicity ( 38 ) . Extensive animal research has shown that morphine
in deaths related to the increase in prescribed opioid use in recent years. Taking all of the evidence into consideration, whenever possible, it may be time to consider other choices (e.g., non-steroidal anti-infl ammatory drugs) for non-cancer chronic pain, which is a common medical problem across the globe.
In addition to increasing the risk of several chronic digestive disease, it is interesting that long-term opioid use has also been shown to increase the rate of hair graying, advanced dental disease, psychiatric disorders and a relative reduction in circulating stem cell numbers, a finding which is associated with the human aging process. Possible pathways explaining negative effects of opioids on stem cells include interference with the cell cycle via P16 at the G1 / S transition, immune disturbance due to cross-interference between Toll-like receptor signaling and retinoic acid inducible protein-1 (RIG-I-like receptors; RLR ' s), and other pathways. Some of these molecular pathways are also known to be involved in the development and progression of chronic digestive disease, cardiovascular disease, and cancer ( 61, 63, 64 ) .
Our study has several strengths, including its large sample size, prospective design, minimal loss to follow-up ( 22, 23 ) , prior validation of exposures ( 24 ) and outcome measures ( 25 ) , and the availability of data to adjust for many potential confounders ( 15, 23 ) . We also used several methods to analyze whether the results were causal. Our study also has some limitations, such as possible outcome misclassifi cation due to using verbal autopsy alone to ascertain the cause of death in 35 % of the deaths.
In summary, the fi ndings of this study suggest an increased risk of mortality due to malignant and non-malignant GI-related causes of death in opium users, compared with never users. Although the non-experimental design hampers making a strong causal conclusion for this increased risk, all analyses conducted in this study, as well as the results of other published studies, suggest that the association is indeed causal.
